Comprehensive evaluations of promising integrated chronic care projects for multi-morbidity using MCDA


The MCDA method developed in WP4 will be used to evaluate the 16 promising ICC for multi-morbidity projects selected in WP1, and extensively described in WP2. Overall the objectives of this work package are:


  1. The evaluation of two ICC for multi-morbidity projects per partner country.
  2. To investigate whether results differ by gender, socio-economic status, cultural background, and risk group.
  3. To develop and apply a performance monitoring tool.


In this work package study protocols, applying the study designs selected in WP4, will be written for each of the ICC projects that will be evaluated. These are the projects that were identified in WP1 and described extensively in WP2. Data will be collected on the performance indicators and MCDA’s will be conducted. Hereafter, a user-friendly performance monitoring tool based on the MCDA will be developed in Excel and made freely accessible online.


University of Bergen (UiB), Department of Economics, Norway

Other partners involved:

  • Erasmus University Rotterdam (EUR), Erasmus School of Health Policy & Management (ESHPM), Netherlands
  • Consorci Institut D’Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Hospital Clinic de Barcelona, Spain
  • Technical University Berlin (TUB), Department of Health Care Management, Germany
  • Syreon Research Institute (SRI), Hungary
  • University of Manchester (UNIMAN), Manchester Centre for Health Economics (MCHE), United Kingdom
  • Institute for Advanced Studies (IHS), Department of Economics and Finance, Austria
  • Agency for Quality and Accreditation in Health Care and Social Welfare (AAZ), Department for Development, Research and HTA, Croatia